2011
DOI: 10.2217/rme.11.24
|View full text |Cite
|
Sign up to set email alerts
|

Advances in Bone Marrow-Derived Cell Therapy: CD31-expressing Cells as Next Generation Cardiovascular Cell Therapy

Abstract: In the past few years, bone marrow (BM)-derived cells have been used to regenerate damaged cardiovascular tissues post-myocardial infarction. Recent clinical trials have shown controversial results in recovering damaged cardiac tissue. New progress has shown that the underlying mechanisms of cell-based therapy relies more heavily on humoral and paracrine effects rather than on new tissue generation. However, studies have also reported the potential of new endothelial cell generation from BM cells. Thus, effort… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
18
0

Year Published

2012
2012
2019
2019

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(18 citation statements)
references
References 136 publications
(178 reference statements)
0
18
0
Order By: Relevance
“…Furthermore, BM-CD31 + cells induced the activation of angiogenic, anti-apoptotic and chemo-attractant factors in ischemic hind-limbs via a paracrine effect. Transplantation with BM-CD31 + cells significantly increased angiogenesis and improved recovery from ischemia 42,43. Jagged1 has been shown to drive immature BM progenitor cells to differentiate into functional EPCs [44].…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, BM-CD31 + cells induced the activation of angiogenic, anti-apoptotic and chemo-attractant factors in ischemic hind-limbs via a paracrine effect. Transplantation with BM-CD31 + cells significantly increased angiogenesis and improved recovery from ischemia 42,43. Jagged1 has been shown to drive immature BM progenitor cells to differentiate into functional EPCs [44].…”
Section: Discussionmentioning
confidence: 99%
“…With respect to ECs, CD31 has been shown to be involved in cell-to-cell contacts, providing a role in the maintenance of vascular integrity [1]. With respect to neutrophils, monocytes, and progenitor cells, CD31 is involved in mediating trans-endothelial migration, a key step in both inflammation and angiogenesis [2-4]. CD31 has been shown to promote interactions between ECs and monocytes, including the activation of antiapoptotic pathways [5].…”
mentioning
confidence: 99%
“…There are numerous reports that human ASCs (hASCs) can both differentiate into endothelial lineage cells in vitro and have a proangiogenic action in ischemia models (Miranville et al, 2004; Planat‐Benard et al, 2004; Ning et al, 2009). Postnatal EPCs and MSCs are found only at low levels in BM and circulation, therefore, limiting their therapeutic application in regenerative medicine, such as cell therapy and tissue engineering (Kim et al, 2011). However, hASCs are regarded as an attractive cell source for therapeutic angiogenesis because large numbers are easily obtained.…”
mentioning
confidence: 99%